Short notes comparison between hdf and hd for dialysis patients and which is better..give in poster form
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Generating Image
HD vs HDF — Key Notes (Evidence-Based Summary)
Mechanism
| Feature | HD | HDF |
|---|---|---|
| Transport | Diffusion only | Diffusion + Convection |
| Membrane | Low-flux or high-flux | High-flux (mandatory) |
| Water requirement | Standard purified | Ultrapure, sterile (used as substitution fluid) |
Solute Clearance
| Solute | HD | HDF |
|---|---|---|
| Small molecules (urea, creatinine) | ✅ Excellent | ✅ Excellent |
| Middle molecules (β₂-microglobulin) | ⚠️ Limited (better with high-flux) | ✅ Superior |
| Protein-bound solutes | ❌ Poor | ⚠️ Marginal improvement |
- HDF mimics glomerular filtration more closely — convective drag removes larger uremic toxins alongside bulk water flow
- β₂-microglobulin is significantly lower in HDF patients than HD patients
Hemodynamic Stability
- HDF is associated with better intradialytic cardiovascular stability and less frequent hypotension — accepted across Europe as an advantage, though disputed by some studies
- HD remains more prone to intradialytic hypotension, especially at high ultrafiltration rates
Dose Targets
- HD: spKt/V ≥ 1.4 per session (thrice weekly); minimum 1.2
- HDF: Effective convective volume (CV) >23 L/session (postdilution); ≥30 L/wk/m² body surface area to achieve survival benefit
Key Clinical Trials
| Trial | Finding |
|---|---|
| ESHOL (~23 L CV) | ↓ All-cause mortality, CV mortality, hospitalization with HDF |
| CONTRAST | No overall survival difference; benefit only in high-CV subgroup (>22 L) |
| Turkish OL-HDF | No overall mortality benefit; benefit in high-CV subgroup (>17.4 L) |
| HEMO / MPO | High-flux HD: no overall mortality benefit; CV mortality ↓15% in subgroups |
Individual patient data meta-analysis: Patients receiving >23 L effective CV in postdilution HDF had significantly lower mortality risk.
Availability & Cost
| HD | HDF | |
|---|---|---|
| Availability | Worldwide, including USA | Europe & select countries; not FDA-approved in USA |
| Cost | Lower | Higher (ultrapure water system, substitution fluid) |
Which is Better?
HDF is NOT universally superior. The evidence supports:
- ✅ HDF preferred when high convection volumes (>23 L/session) are consistently achievable, for patients with hemodynamic instability, high middle molecule burden, or long dialysis vintage
- ✅ High-flux HD remains the standard of care where HDF is unavailable and is a clinically valid alternative
- ⚠️ Low-volume HDF offers no proven advantage over high-flux HD — the benefit is volume-dependent
- 🔬 Additional high-quality RCTs addressing convection volume thresholds are still needed
Sources: Comprehensive Clinical Nephrology 7th Ed. | Brenner & Rector's The Kidney
Summary
HD vs HDF — Summary
HD (Hemodialysis) uses diffusion only to clear small molecules (urea, creatinine) across a semipermeable membrane. It's the global standard, widely available, lower cost, but limited in removing middle molecules and prone to intradialytic hypotension.
HDF (Hemodiafiltration) combines diffusion + convection, using a high-flux membrane to remove both small AND middle molecules (β₂-microglobulin, uremic toxins). It requires ultrapure water, is more expensive, and is unavailable in the USA.
Key Differences at a Glance
| HD | HDF | |
|---|---|---|
| Mechanism | Diffusion | Diffusion + Convection |
| Middle molecule removal | Limited | Superior |
| Hemodynamic stability | Poorer | Better |
| Water requirement | Standard | Ultrapure (sterile) |
| Cost | Lower | Higher |
| USA availability | ✅ | ❌ |
Which is Better?
HDF wins — but only conditionally:
- Benefit is dose-dependent: requires >23 L convective volume/session
- At high volumes → lower all-cause mortality, CV mortality, and hospitalization (ESHOL trial)
- At low volumes → no advantage over high-flux HD
- High-flux HD remains a valid, evidence-backed standard where HDF is unavailable
Bottom line: HDF > HD in hemodynamic stability and middle molecule clearance. For mortality benefit, high-volume HDF (>23 L) is the target — otherwise, high-flux HD is equally acceptable.
This is a shared conversation. Sign in to Orris to start your own chat.